Tissue engineering & cell therapy

[Patrick Driscoll]

MedMarket Diligence has released its 2010 report on Tissue Engineering, Cell Therapy and Transplantation. The report examines the $6.9 billion global market for cell-based, biomaterials and other products providing therapeutic benefits in via stem and other pluripotent cells, and other products providing tissue replacement or regenerative roles.

The report is detailed at http://www.mediligence.com/rpt/rpt-s520.htm.

Cell therapy and tissue engineering are targeting applications across the clinical spectrum.  See the "map" at the advanced medical technologies blog. 

See also coverage of cell therapy and tissue engineering the "advanced medical technologies" blog